EC Number | Application | Comment | Organism |
---|---|---|---|
1.14.14.154 | drug development | CYP51 is a potential anticholesterolemic drug target | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.154 | 1-(phenethyl(propyl)amino)-3-(pyridin-3-yloxy)propan-2-ol | - |
Homo sapiens | |
1.14.14.154 | 2-(2-(naphthalen-2-yl)ethyl](propyl)amino]-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(2-chlorophenethyl(propyl)amino)-1-(pyridin-4-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(3,4-dichlorophenethyl(methyl)amino)-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(3,4-dichlorophenethyl(methyl)amino)-1-(pyridin-4-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(3,4-dichlorophenethyl(propyl)amino)-1-(4-methylpyridin-2-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(3,4-dichlorophenethyl(propyl)amino)-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(3,4-dichlorophenethyl(propyl)amino)-1-phenylethanol | - |
Homo sapiens | |
1.14.14.154 | 2-(3,4-difluorophenethyl(propyl)amino)-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(3,4-dimethoxyphenethyl(propyl)amino)-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(4-chlorophenethyl(propyl)amino)-1-(pyridin-4-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(4-nitrophenethyl(propyl)amino)-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(phenethyl(propyl)amino)-1-(pyridin-3-yl) ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(propyl(2-(trifluoromethyl)phenethyl)amino)-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-(propyl(4-(trifluoromethyl)phenethyl)amino)-1-(pyridin-3-yl)ethanol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | 2-{propyl[2-(pyridin-3-yl)ethyl]amino}-1-(pyridin-3-yl)ethanol | - |
Homo sapiens | |
1.14.14.154 | 4-(2-(2-hydroxy-2-(pyridin-3-yl)ethyl)(propyl)amino)ethylbenzene-1,2-diol dihydrobromide | - |
Homo sapiens | |
1.14.14.154 | fluconazole | - |
Homo sapiens | |
1.14.14.154 | ketoconazole | - |
Homo sapiens | |
1.14.14.154 | additional information | structureactivity relationship study of enzyme-ligand binding, pyridine binds within the heme binding pocket in an analogy with azoles, overview | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.14.14.154 | endoplasmic reticulum | - |
Homo sapiens | 5783 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.154 | Fe2+ | a cytochrome P450 enzyme | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.154 | 24,25-dihydrolanosterol + [reduced NADPH-hemoprotein reductase] + O2 | Homo sapiens | - |
(3beta,5alpha)-4,4-dimethylcholesta-8,14-dien-3-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | lanosterol + [reduced NADPH-hemoprotein reductase] + O2 | Homo sapiens | - |
4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | additional information | Homo sapiens | the enzyme catalyzes a step in the cholesterol biosynthesis via the mevalonate pathway, overview | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.14.154 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.14.154 | Hep-G2 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.154 | 24,25-dihydrolanosterol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Homo sapiens | (3beta,5alpha)-4,4-dimethylcholesta-8,14-dien-3-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | lanosterol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Homo sapiens | 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | additional information | the enzyme catalyzes a step in the cholesterol biosynthesis via the mevalonate pathway, overview | Homo sapiens | ? | - |
? | |
1.14.14.154 | additional information | structure-activity relationship study of enzyme-ligand binding, pyridine binds within the heme binding pocket in an analogy with azoles, overview | Homo sapiens | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.14.14.154 | CYP51 | - |
Homo sapiens |
1.14.14.154 | lanosterol 14alpha-demethylase | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.154 | cytochrome P450 | a cytochrome P450 enzyme | Homo sapiens |